Randomized Double Blind Placebo-Controlled Parallel Group, MultiCenter Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Larg

Administered By

Awarded By

Contributors

Start/End

  • July 26, 2018 - January 29, 2021